RT Book, Section A1 Nastoupil, Loretta J. A1 Cheah, Chan Yoon A1 Medeiros, L. Jeffrey A1 Fowler, Nathan H. A2 Kantarjian, Hagop M. A2 Wolff, Robert A. SR Print(0) ID 1126740415 T1 Indolent Lymphomas T2 The MD Anderson Manual of Medical Oncology, 3e YR 2016 FD 2016 PB McGraw-Hill Medical PP New York, NY SN 9780071847940 LK hemonc.mhmedical.com/content.aspx?aid=1126740415 RD 2024/03/29 AB The indolent non-Hodgkin lymphomas (NHLs) represent approximately one-third of all malignant lymphomas (1,2); most are of B-cell lineage. Follicular lymphoma (FL) is the most common indolent lymphoma. Other indolent B-cell lymphomas include small lymphocytic lymphoma/chronic lymphocytic leukemia (SLL/CLL), the marginal zone B-cell lymphomas (MZLs; extranodal, nodal, and splenic), and lymphoplasmacytic lymphoma (LPL), most cases of which are more specifically classified as Waldenström macroglobulinemia (WM) (Table 7-1) (2). Mantle cell lymphoma can morphologically resemble indolent B-cell lymphomas, but it is often clinically more aggressive and therefore is not covered in this chapter. Indolent T-cell NHLs, such as mycosis fungoides, are also not covered in this chapter.